Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet (London, England). 2014;383(9927):1490–502.
Article
Google Scholar
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians. 2014;64(1):9–29.
Gay LJ, Mitrou PN, Keen J, Bowman R, Naguib A, Cooke J, et al. Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC-Norfolk study. J Pathol. 2012;228(3):405–15.
Article
CAS
Google Scholar
Goncalves MD, Lu C, Tutnauer J, Hartman TE, Hwang SK, Murphy CJ, Pauli C, Morris R, Taylor S, Bosch K, Yang S. High-fructose corn syrup enhances intestinal tumor growth in mice. Science. 2019;363(6433):1345–9.
Article
CAS
Google Scholar
Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer a meta-analysis. JAMA-J Am Med Assoc. 2008;300(23):2765–78.
Article
CAS
Google Scholar
Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta-analysis. Int J Cancer. 2009;124(10):2406–15.
Article
CAS
Google Scholar
Inoue M, Tajima K, Hirose K, Hamajima N, Takezaki T, Hirai T, et al. Subsite-specific risk factors for colorectal cancer: a hospital-based case-control study in Japan. Cancer Causes control. 1995;6(1):14–22.
Article
CAS
Google Scholar
Zisman AL, Nickolov A, Brand RE, Gorchow A, Roy HK. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med. 2006;166(6):629–34.
Article
Google Scholar
Sharpe CR, Siemiatycki JA, Rachet BP. The effects of smoking on the risk of colorectal cancer. Dis Colon Rectum. 2002;45(8):1041–50.
Article
Google Scholar
Hu J, Morrison H, Mery L, DesMeules M, Macleod M. Diet and vitamin or mineral supplementation and risk of colon cancer by subsite in Canada. European J Cancer Prevention. 2007;16(4):275–91.
Article
CAS
Google Scholar
Ben-Aharon I, Goshen-Lago T, Sternschuss M, Morgenstern S, Geva R, Beny A, et al. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location. The oncologist. 2019.
Petrelli F, Tomasello G, Borgonovo K, Ghidini M, Turati L, Dallera P, et al. Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis. JAMA oncology. 2016.
Tejpar S, Stintzing S, Ciardiello F, Tabernero J, Van Cutsem E, Beier F, et al. Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials. JAMA oncology. 2016.
Jayasekara H, English DR, Haydon A, Hodge AM, Lynch BM, Rosty C, et al. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype. Int J Cancer. 2018;142(2):238–50.
Article
CAS
Google Scholar
Karim S, Brennan K, Nanji S, Berry SR, Booth CM. Association between prognosis and tumor laterality in early-stage colon cancer. JAMA Oncol. 2017;3(10):1386–92.
Article
Google Scholar
Altman DG, Bland JM. Statistics Notes-Interaction revisited: the difference between two estimates. BMJ British Medical J. 2003;326(7382):219.
Article
Google Scholar
Venook AP, Ou FS, Lenz HJ, Kabbarah O, Qu XP, Niedzwiecki D, et al. Primary (1 degrees) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance). J Clin Oncol. 2017;35:5.
Article
Google Scholar
Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3(10):733–44.
Article
CAS
Google Scholar
Diergaarde B, Vrieling A, van Kraats AA, van Muijen GNP, Kok FJ, Kampman E. Cigarette smoking and genetic alterations in sporadic colon carcinomas. Carcinogenesis. 2003;24(3):565–71.
Article
CAS
Google Scholar
Carr PR, Alwers F, Bienert S, Weberpals J, Kloor M, Brenner H, et al. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses. Ann Oncol. 2018;29(4):825–34.
Article
CAS
Google Scholar
Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010;102(14):1012–22.
Article
CAS
Google Scholar
Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut. 2012;61(6):847–54.
Article
CAS
Google Scholar
Natsume S, Yamaguchi T, Takao M, Iijima T, Wakaume R, Takahashi K, et al. Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients. Jpn J Clin Oncol. 2018;48(7):609–18.
Article
Google Scholar
Shen H, Yang J, Huang Q, Jiang MJ, Tan YN, Fu JF, et al. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol. 2015;21(21):6470–8.
Article
CAS
Google Scholar
Loupakis F, Yang D, Yau L, Feng S, Cremolini C, Zhang W, et al. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst. 2015;107(3).
Kajizono M, Saito M, Maeda M, Yamaji K, Fujiwara S, Kawasaki Y, et al. Cetuximab-induced skin reactions are suppressed by cigarette smoking in patients with advanced colorectal cancer. Int J Clin Oncol. 2013;18(4):684–8.
Article
CAS
Google Scholar
Abdel-Rahman O, Cheung WY. Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study. Med Oncol. 2018;35(5):68.
Article
Google Scholar
Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, et al. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials. Oncologist. 2015;20(3):307–15.
Article
CAS
Google Scholar
Kawaguchi C, Sho M, Tanaka T, Akahori T, Kinoshita S, Nagai M, et al. Impact of smoking on pancreatic cancer patients receiving current chemotherapy. Pancreas. 2015;44(7):1155–60.
Article
CAS
Google Scholar
Kelemen LE, Warren GW, Koziak JM, Kobel M, Steed H. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer. Gynecol Oncol. 2016;140(1):124–30.
Article
Google Scholar
Desrichard A, Kuo F, Chowell D, Lee KW, Riaz N, Wong RJ, et al. Tobacco smoking-associated alterations in the immune microenvironment of squamous cell carcinomas. J Natl Cancer Inst. 2018;110(12):1386–92.
Article
Google Scholar
Zhou GB, Norum J, Nieder C. Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature. Nat Commun. 2018;3(6):e000406.
Google Scholar